The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Poster Presentation(E) Pharmaceutical Health Care and Sciences

[27-55-am]Pharmaceutics 2, Transporters/ADME/PK-PD

Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 55 (C202, Bldg. 2, Area 2 [2F]) (2)
Discusser: Satomi Onoue, Shinji Sakuma

[27-55-am-08]Evaluation of PMAT-mediated transport of amiloride as a fluorescent probe substrate

○Takahiro Yamashiro1, Ichika Ohya1, Tomoya Yasujima1, Hiroaki Yuasa1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ.)

[27-55-am-09S]Plasma concentration of the SGLT2 inhibitor dapagliflozin and its effect on urinary excretion of the blood glucose biomarker 1,5-anhydroglucitol in rats

○Manaka Mukai1, Hideyuki Motohashi1, Asuka Io1, Yumiko Takebayashi1, Junya Nagai1 (1. Osaka Medical and Pharmaceutical Univ.)

[27-55-am-10S]Evaluation of dacarbazine pharmacokinetics and their relationship to drug efficacy and toxicity

○Tamako Nagamura1, Azusa Imanishi1, Yu Nakai1, Shugo Yamashita1, Akiko Kiriyama1 (1. Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts)

[27-55-am-11S]Development of Physiologically Based Pharmacokinetic Model explaining in vivo and ex vivo transplacental IgG transfer

○Mayuko Fujisaki1, Toshiaki Tsuchitani1, Saki Noguchi1, Masatoshi Tomi1 (1. Facul. Pharm., Keio Univ)

[27-55-am-12S]Drug interaction between the selective aldosterone antagonist eplerenone and the CYP3A4 inhibitor erythromycin in vitro

○Kanami Hibi1, Takahiko Aoyama1, Fumihiro Kurosaki1, Yuichi Matsumoto1, Kanta Sanekata1, Yurika Shimakawa1, Toshinori Hirai2, Yasuhiro Tsuji1 (1. Sch. Pharm., Nihon Univ., 2. Institute of Science Tokyo Hospital, Department of Pharmacy)

[27-55-am-13S]Risk assessment of drug interactions mediated by citrus marmalades: inhibition of CYPs and OATPs in the gastrointestinal tract

○Hirari Aoki1, Madoka Suwa1, Tomoki Arai1, Ayuko Imaoka1, Takeshi Akiyoshi1,2, Hisakazu Ohtani1,2,3 (1. Fac. Pharm., Keio Univ., 2. Sch. Med., Keio Univ., 3. Dept. Pharm., Keio Univ. Hosp.)

[27-55-am-14S]Association between pemafibrate administration and muscle and renal disorders: database analysis and animal study

○Hanami Ito1, Akane Moriwaki1, Shinji Kobuchi1, Ryo Inose1, Yukako Ito1, Yuichi Muraki1, Toshiyuki Sakaeda1 (1. Kyoto Pharm. Univ.)
Back to Category List